Short-Term Debt to Capital: NeuroMetrix Inc (NURO)

This chart of the current market value of NeuroMetrix, Inc. (NURO) reflects the dynamics of a company whose success depends on the recognition of the Quell system in fibromyalgia therapy and the advancement of neuromodulation. The business generates revenue from the sale of wearable stimulators and diagnostic systems for neurologists and patients with neuropathy. Thanks to the diversification of electronics suppliers, logistics remain stable, and the current figure stands at 0.01.

This ratio compares liabilities with a maturity of up to one year against equity, allowing investors to filter out market noise from the actual debt load, while analyzing the level of short-term borrowed capital relative to equity is critically important for NeuroMetrix, Inc. (NURO), as pricing pressure in the wearable device retail market limits margins and impacts the company's ability to service current loans.